Did you know the pharmaceutical market in #SaudiArabia is growing rapidly, and is expected to reach $11.5 billion by 2032.
Factors driving growth include:
Government investment in healthcare infrastructure
Rising healthcare expenditure
Collaborations between local and international pharmaceutical companies
Medical tourism
I am delighted to be attending CPHI Middle East 8th-10th December. #Connect with me to hear how Sterling Bell Leadership advisory is on the ground in #Riydah, providing solutions including #leadershipprogrammes, #assessments in addition to #executiverecruitment in the #pharmaceutical and #heathcare sectors.
Saudi Arabia is making bold strides to transform its pharmaceutical sector, propelled by a wave of transformative investments.
At the inaugural Convention on Pharmaceutical Ingredients (CPHI) Middle East event in Riyadh, over $798 million USD worth of investment deals were announced, focusing on research, manufacturing, and logistics.
These initiatives solidify the Kingdom’s position as a regional pharma leader, contributing to health security and economic growth.
#CPHIMiddleEast#SaudiPharma#InnovationInHealthcare#SickleCellDisease#Thalassemia#HealthTransformation
India’s pharmaceutical industry continues to showcase its potential on the global stage, and partnerships like those with the UAE are instrumental in unlocking opportunities in Africa and the Middle East. These collaborations not only strengthen India’s position as a trusted healthcare partner but also play a crucial role in addressing critical healthcare challenges and ensuring access to essential medicines in emerging economies. Looking forward to insights from this important discussion on advancing global healthcare!
India’s pharmaceutical industry has emerged as a global leader 🌍
Now, Africa and the Middle East, driven by partnerships with the UAE, are unlocking new opportunities for India’s pharma exports.
Join us to explore:
- The dynamic collaboration between India and the UAE
- How partnerships are addressing growing healthcare challenges
- Strategies to improve access to essential medicines in emerging economies
Don’t miss this critical conversation on the future of global healthcare collaboration!
🔗Book Now: https://lnkd.in/gvZmyBGH#PharmaFrontiers#IndiaPharma#HealthcareInnovation#EmergingEconomies#IGFUAE#DubaiEventsNamit JoshiRAJA BHANUMadhukar Tanna
📣 The Spanish Government Unveils the 2024-2028 Pharmaceutical Industry Strategy
Public procurement emerges as a cornerstone in the new Pharmaceutical Industry Strategy, with measures aimed at ensuring equitable access, driving innovation, and fostering sustainability in the healthcare sector.
𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:
🛒 𝐏𝐮𝐛𝐥𝐢𝐜 𝐏𝐫𝐨𝐜𝐮𝐫𝐞𝐦𝐞𝐧𝐭
- Streamlined 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞𝐬 and harmonized 𝐜𝐫𝐢𝐭𝐞𝐫𝐢𝐚 for more efficient tendering processes.
- Innovation-focused public procurement and 𝐨𝐮𝐭𝐜𝐨𝐦𝐞-𝐛𝐚𝐬𝐞𝐝 𝐜𝐨𝐧𝐭𝐫𝐚𝐜𝐭𝐬 to drive disruptive solutions.
- Integration of 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭𝐚𝐥 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐜𝐫𝐢𝐭𝐞𝐫𝐢𝐚, including carbon footprint, in procurement decisions.
- Enhanced transparency and flexibility in 𝐩𝐫𝐢𝐜𝐢𝐧𝐠, prioritizing strategic medicines.
💉 𝐁𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐬
- Policies promoting biosimilar adoption, 𝐫𝐞𝐝𝐮𝐜𝐢𝐧𝐠 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐜𝐨𝐬𝐭𝐬 while ensuring market competitiveness.
- Tailored 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐦𝐨𝐝𝐞𝐥𝐬 addressing production challenges while fostering innovation.
- Specific public procurement criteria to ensure their 𝐚𝐜𝐜𝐞𝐬𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲 within the healthcare system.
These measures aim to strengthen the National Health System, promote innovation, and build a more sustainable pharmaceutical industry.
🔎 Explore the 𝐟𝐮𝐥𝐥 𝐫𝐞𝐩𝐨𝐫𝐭 and our 𝐬𝐮𝐦𝐦𝐚𝐫𝐲 in the comments.
#PublicProcurement#ValueBasedContracts#PharmaceuticalStrategy#Biosimilars#Acobur
Join us in our latest podcast episode for a discussion on the transformative changes in Africa’s health and pharmaceutical sector.
In this episode, our host, Justina Okachi, sits down with our Partner, Amala Umeike, to explore the dynamic developments and emerging opportunities in Africa's pharmaceutical industry.
Amala provides an in-depth overview of the continent’s rapidly evolving pharmaceutical landscape, highlighting key trends such as population dynamics, disease prevalence, government initiatives, and local manufacturing capabilities.
He also addresses the critical concerns of data protection and privacy in the wake of digital health initiatives, emphasizing the need for robust safeguards and regular data protection audits to maintain patient trust and uphold ethical standards.
Amala further highlights the growing importance of regulatory compliance, citing the increased oversight by agencies like the Federal Competition & Consumer Protection Commission (FCCPC), which has intensified focus on mergers & acquisitions and antitrust issues within the pharmaceutical sector. This regulatory vigilance, combined with the sector’s high profit margins and the significant growth potential in areas such as generic medications and oncology, demonstrates the opportunities for transformative development in Africa’s pharmaceutical landscape.
Click the link below to watch the full video.
https://lnkd.in/dvgG9hVc
To learn about our health and pharmaceutical sector, please reach out to contact@strenandblan.com.
#strenandblanpartner#commerciallawfirm#healthsector#pharmaceuticalsector
Exciting news for the pharmaceutical industry! On June 13, 2024, USP announced a groundbreaking collaboration with African institutions to provide free access to resources aimed at improving the production of quality medical products across the continent. This initiative is a significant step towards ensuring that high-quality medical products are available to all, enhancing public health outcomes.
By making these resources accessible, USP and its African partners are empowering local manufacturers with the tools and knowledge needed to adhere to international quality standards. This collaboration not only supports the production of essential medicines but also fosters innovation and strengthens the healthcare infrastructure in Africa.
This is a fantastic example of how global cooperation and shared expertise can lead to impactful improvements in healthcare. Kudos to USP and the participating African institutions for leading this important initiative!
#Pharmaceuticals#QualityAssurance#Healthcare#Africa#USP#PublicHealth#GlobalCollaboration
Unlock “The jigsaw of value approaches for innovative pharmaceutical products” with Dr. Hussain Al-Omar (Associate Professor of Pharmacoeconomics at King Saud University)
Join us at MENAHTA Forum 2024 as we delve into the broad spectrum of health technology assessments. From understanding HTA principles to exploring diverse modalities and cost-containment strategies, it's a journey you won't want to miss.
Register now and be part of the conversation shaping the future of healthcare!
Follow MENAHTA Forum on LinkedIn for more updates!
#MENAHTAForum#Pharmaexpert#MENAHTAForum2024#Agenda#Pharmacoeconomics
The #futurehealthsummit over the last few days in Dublin brought together representatives from over 120 pharmaceutical and biotechs. These companies are not only at the forefront of medical innovation but also play a crucial role in Ireland's economy.
Novartis was proud to be one of the joint sponsors of the event as we recognised innovation and the provision of high-quality opportunities for patients. The healthcare and pharma sectors collectively employ over 30,000 people in Ireland, offering high-quality jobs and career opportunities in research, manufacturing, and healthcare services.
The #futurehealthsummit recognised and celebrated the contribution of these industries to Ireland's GDP. In 2023, the pharma sector alone accounted for approximately €80 billion in exports, solidifying Ireland's position as a global leader in pharmaceutical production and innovation.
#FutureHealthSummit#HealthcareInnovation#PharmaIndustry#IrelandEconomy#DublinSummit#HealthcareLeadership#GlobalHealth
